Palvella Therapeutics, Inc. · NASDAQ:PVLA
Palvella Therapeutics, Inc. shareholders
As of Jun 30, 2026, 189 institutions reported holding Palvella Therapeutics, Inc., 97.8% of its shares. Largest: Montanova Capital, LLC, Jennison Associates LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Palvella Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Montanova Capital, LLC | 1.14M | 7.9% | −18,090 | Aug 14, 2026 |
| Jennison Associates LLC | 961K | 6.7% | +320K | Aug 3, 2026 |
| BlackRock | 918K | 6.4% | +232K | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 882K | 6.1% | no change | Aug 14, 2026 |
| First Light Asset Management, LLC | 772K | 5.4% | −209K | Aug 14, 2026 |
| Vanguard | 732K | 5.1% | +83,816 | Aug 13, 2026 |
| Bvf Inc | 673K | 4.7% | −288K | Aug 14, 2026 |
| State Street | 653K | 4.5% | +194K | Aug 7, 2026 |
| T. Rowe Price | 639K | 4.4% | +236K | Aug 14, 2026 |
| Frontier Capital Management Co LLC | 479K | 3.3% | +105K | Aug 14, 2026 |